CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: April-21-16
Credit Expiration Date: April-21-17


Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Director, Florida Hospital Diabetes Institute
Senior Scientist, Translational Research Institute for Metabolism and Diabetes
Orlando, FL

Carol H. Wysham, MD, FACP, FACE
Clinical Associate Professor of Medicine
University of Washington School of Medicine
Spokane, WA 

John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sydney Kimmel College of Medicine
Philadelphia, PA

Credit Hours

Physicians: 0.75 AMA PRA Category 1 CreditTM
Pharmacists: 0.75 Contact Hour (0.075 CEU)
Nurses: 0.75 Contact Hours



Program Description

Approximately 26% of adults over age 65 in the US (11.2 million people) have diabetes. This is a heterogeneous population that includes individuals residing independently in communities, in assisted living, and in skilled nursing facilities. Management of diabetes in older adults should be carefully tailored, taking into account these variables. All members of the care team, including physicians, NPs, PAs, pharmacists, and nurses have a role to play in ensuring the best possible outcomes for their older adult patients. This activity examines the keys to individualizing treatment plans.

Program Developer/Facilitator


Target Audience

This activity is intended for senior care clinicians, including physicians, NPs, PAs, pharmacists, nurses, and others who encounter older adults with T2DM.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Discuss clinical and safety factors that must be considered when setting glycemic goals for older patients with T2DM.
  2. Implement treatment adjustments for older adults with T2DM experiencing hypoglycemia.


It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and the credit providers have a process in place to resolve any conflict of interest.

Richard E. Pratley, MD, has disclosed the following:
Consultant: AstraZeneca, Boehringer Ingelheim, Glaxo Smith Kline, Hanmi Pharmaceutical Co., Ltd., Janssen Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., Lilly, Merck, Novo Nordisk, Takeda
Speakers Bureau: AstraZeneca, Novo Nordisk
Research/Grant Support: Lilly, Merck, Novo Nordisk, Sanofi Aventis US, LLC, Takeda

Carol H. Wysham, MD, FACP, FACE, has disclosed the following:
Consultant: AstraZeneca, Boehringer Ingelheim, Lilly, Janssen Pharmaceuticals, Inc., Sanofi Aventis US, LLC
Speakers Bureau: AstraZeneca, Boehringer Ingelheim, Lilly, Janssen Pharmaceuticals, Inc., Novo Nordisk, Sanofi Aventis US, LLC
Research/Grant Support: AstraZeneca, Boehringer Ingelheim, Lilly, Janssen Pharmaceuticals, Inc., Merck, Novo Nordisk, Sanofi Aventis US, LLC

John J. Russell, MD, has disclosed the following:
Consultant: Galderma
Speakers Bureau: Sanofi Pasteur

Penn State and ASCP staff involved in the development and review of this activity have nothing to disclose.

Global Disclosures: Ashley Marostica, RN, MSN - Nothing to disclose, Amanda Glazar, PhD - Nothing to disclose, Andrea Funk - Nothing to disclose

Don Harting, MCM Education, Writer/Editor, has nothing to disclose.

Kathleen Hines, MCM Education, Vice President, Editorial Services, has nothing to disclose.

Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.

Credit Statements

Credit is awarded to participants who score 80% or better on the post-test.

The online activity will take approximately 45 minutes to complete.

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Penn State College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit, contact Penn State Continuing Education at (717) 531-6483 or Please reference activity code G5920-16-T.

Pharmacy Continuing Education
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity Number: 0203-9999-16-029-H01-P, has been assigned 0.75 Contact Hour (0.075 CEU).

Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit.

Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 0.75 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity is jointly provided by Global Education Group and MCM Education.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or

Commercial Support Statements

Supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.


  1. There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity.
  2. Review the intended audience, learning objectives, and author disclosures.
  3. Study the educational content online.
  4. Once completed, continue to post-test. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
  5. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee



The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Penn State College of Medicine, the American Society of Consultant Pharmacists (ASCP), Global Education Group, or Takeda Pharmaceuticals U.S.A., Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu